🇩🇪 Germany Country × Condition
glioblastoma Clinical Trials in Germany
Active clinical trials for glioblastoma with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇪 Germany
Active Trials in Germany (3)
NCT06273176
Recruiting
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Enrollment
225 pts
Country
🇩🇪 Germany
Erasmus Medical Center
View Trial → NCT06118723
Recruiting
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Enrollment
784 pts
Country
🇩🇪 Germany
Jasper Gerritsen
View Trial → NCT05590689 Phase 1, Phase 2
Recruiting
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
Enrollment
34 pts
Country
🇩🇪 Germany
Universität Münster
View Trial → Frequently Asked Questions
How many glioblastoma clinical trials are active in Germany?
There are currently 3 active clinical trials for glioblastoma with sites in Germany, of which 3 are actively recruiting patients.
How can I join a glioblastoma clinical trial in Germany?
To join a glioblastoma clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are glioblastoma trials in Germany?
Active glioblastoma trials in Germany span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology